Literature DB >> 6051385

Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.

N Tamura, R A Nelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6051385

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  48 in total

1.  Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.

Authors:  H Okada; N Okada
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  Opsonizing activities of IgG, IgM antibodies and the C3b inactivator-cleaved third component of complement in macrophage phagocytosis.

Authors:  B Wellek; H Hahn; W Opferkuch
Journal:  Agents Actions       Date:  1976-02

3.  Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

Authors:  S I Rosenfeld; M E Kelly; J P Leddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

4.  Preparation of test cells for the antiglobulin test.

Authors:  F Stratton; V I Rawlinson
Journal:  J Clin Pathol       Date:  1974-05       Impact factor: 3.411

5.  The complement system in renal homograft recipents.

Authors:  T Yokoyama; M Torisu; A L Durst; G Schroter; C G Groth; T E Starzl
Journal:  Surgery       Date:  1972-10       Impact factor: 3.982

6.  A C1-fixation method for the measurement of chicken anti-viral antibody.

Authors:  R L Stolfi; R A Fugmann; J J Jensen; M M Sigel
Journal:  Immunology       Date:  1971-03       Impact factor: 7.397

7.  Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.

Authors:  N Tamura; A S Baba
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

8.  Inactivator of the third component of complement as an inhibitor in the properdin pathway.

Authors:  C A Alper; F S Rosen; P J Lachmann
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

9.  A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.

Authors:  B Wellek; W Opferkuch
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

10.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.